Humacyte rises after positive data from humanitarian study of Symvess
Humacyte(US:HUMA) Seeking Alphaยท2025-10-06 20:09Humacyte (NASDAQ:HUMA) shares surged following the release of data from a humanitarian initiative that utilized their bio-engineered human tissue product Symvess to address vascular trauma injuries. The stock closed up about 18% on Monday. The program involved 17 patients in ...